Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

41 Citeringar (SciVal)
362 Nedladdningar (Pure)

Sammanfattning

Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.
Originalspråkengelska
Sidor (från-till)119-128
TidskriftMolecular Oncology
Volym8
Utgåva1
DOI
StatusPublished - 2014

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här